Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: Effect of hypertension

Journal of the American Geriatrics Society

Volumn 63, Issue 2, 2015, Pages 276-281

  Hajjar, Ihab ^a   Sorond, Farzaneh ^b   Lipsitz, Lewis A ^c,d,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Hebrew Senior Life   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

apolipoprotein E; CO2 vasoreactivity; cognition; hypertension

Indexed keywords

APOLIPOPROTEIN E; CARBON DIOXIDE; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; COGNITION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PSYCHOLOGIC TEST; RECALL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; AGE; BLOOD FLOW VELOCITY; BRAIN CIRCULATION; GENETICS; LUNG GAS EXCHANGE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; TIDAL VOLUME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BLOOD FLOW VELOCITY; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; COGNITION; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; TIDAL VOLUME;

EID: 84923264800     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13235     Document Type: Article

References (31)

1. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998; 279: 751-755.
2. Wilson RS, Schneider JA, Barnes LL, et al. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002; 59: 1154-1160.
3. Wisdom NM, Callahan JL, Hawkins KA,. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiol Aging 2011; 32: 63-74.
4. Stoumpos S, Hamodrakas SJ, Anthopoulos PG, et al. The association between apolipoprotein E gene polymorphisms and essential hypertension: A meta-analysis of 45 studies including 13 940 cases and 16 364 controls. J Hum Hypertens 2013; 27: 245-255.
5. Paglieri C, Bisbocci D, Caserta M, et al. Hypertension and cognitive function. Clin Exp Hypertens 2008; 30: 701-710.
6. Qiu C, Winblad B, Fastbom J, et al. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology 2003; 61: 655-660.
7. Peila R, White LR, Petrovich H, et al. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: The Honolulu-Asia Aging Study. Stroke 2001; 32: 2882-2889.
8. Hauser PS, Narayanaswami V, Ryan RO,. Apolipoprotein E: From lipid transport to neurobiology. Prog Lipid Res 2011; 50: 62-74.
9. Riddell DR, Zhou H, Atchison K, et al. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 2008; 28: 11445-11453.
10. Zlokovic BV,. Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease. JAMA Neurol 2013; 70: 440-444.
11. Nishitsuji K, Hosono T, Nakamura T, et al. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 2011; 286: 17536-17542.
12. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012; 485: 512-516.
13. Bradac GB, Simon RS, Heidsieck CH,. Angiographically verified transient alteration of the intracranial arteries and veins in dependence of different CO2 tensions. Neuroradiology 1976; 10: 257-262.
14. Cantin S, Villien M, Moreaud O, et al. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI. NeuroImage 2011; 58: 579-587.
15. Vicenzini E, Ricciardi MC, Altieri M, et al. Cerebrovascular reactivity in degenerative and vascular dementia: A transcranial Doppler study. Eur Neurol 2007; 58: 84-89.
16. Hajjar I, Zhao P, Alsop D, et al. Hypertension and cerebral vasoreactivity: A continuous arterial spin labeling magnetic resonance imaging study. Hypertension 2010; 56: 859-864.
17. Hajjar I, Marmarelis V, Shin DC, et al. Assessment of cerebrovascular reactivity during resting state breathing and its correlation with cognitive function in hypertension. Cerebrovasc Dis 2014; 38: 10-16.
18. Leveille SG, Kiel DP, Jones RN, et al. The MOBILIZE Boston Study: Design and methods of a prospective cohort study of novel risk factors for falls in an older population. BMC Geriatr 2008; 8: 16. doi: 10.1186/1471-2318-8-16
19. Gordon NG,. The Trail Making Test in neuropsychological diagnosis. J Clin Psychol 1972; 28: 167-169.
20. Corrigan JD, Hinkeldey NS,. Relationships between parts A and B of the Trail Making Test. J Clin Psychol 1987; 43: 402-409.
21. Sorond FA, Galica A, Serrador JM, et al. Cerebrovascular hemodynamics, gait, and falls in an elderly population: MOBILIZE Boston Study. Neurology 2010; 74: 1627-1633.
22. Claassen JA, Zhang R, Fu Q, et al. Transcranial Doppler estimation of cerebral blood flow and cerebrovascular conductance during modified rebreathing. J Appl Physiol 2007; 102: 870-877.
23. Rebeck GW, Reiter JS, Strickland DK, et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993; 11: 575-580.
24. Edwards D, Berry JJ,. The efficiency of simulation-based multiple comparisons. Biometrics 1987; 43: 913-928.
25. Graybill FA,. An Introduction to Linear Statistical Models. New York: McGraw-Hill, 1961.
26. Yu JT, Tan L, Hardy J,. Apolipoprotein E in Alzheimer's disease: An update. Annu Rev Neurosci 2014; 37: 79-100.
27. Hafezi-Moghadam A, Thomas KL, Wagner DD,. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am J Physiol Cell Physiol 2007; 292: C1256-C1262.
28. Folin M, Baiguera S, Guidolin D, et al. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner. Int J Mol Med 2006; 17: 821-826.
29. Guangda X, Linshuang Z, Jie H, et al. Apo e4 allele is associated with endothelium-dependent arterial dilation in women with type 2 diabetes. Diabetes Res Clin Pract 2006; 72: 155-161.
30. Algotsson A, Nordberg A, Winblad B,. Apolipoprotein E varepsilon4 allele has an impact on vascular reactivity in Alzheimer's disease. Arch Gerontol Geriatr 2000; 31: 221-231.
31. Kim SM, Kim MJ, Rhee HY, et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: Effect of APOE epsilon4 allele. Neuroradiology 2013; 55: 25-34.